Israel Englander Mirum Pharmaceuticals, Inc. Transaction History

Millennium Management LLC

$192 Billion
Q2 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 288,159 shares of MIRM stock, worth $18.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

288,159

Previous 479,299 39.88%

Holding current value

$18.6 Million

Previous $21.6 Million 32.09%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$38.39 - $51.11 $7.34 Million - $9.77 Million	-191,140 Reduced 39.88%	288,159 $14.7 Million
Q1 2025 May 15, 2025	SELL	$41.32 - $53.16 $1.97 Million - $2.53 Million	-47,675 Reduced 9.05%	479,299 $21.6 Million
Q4 2024 Feb 14, 2025	BUY	$37.85 - $46.65 $2.7 Million - $3.33 Million	71,410 Added 15.68%	526,974 $21.8 Million
Q3 2024 Nov 14, 2024	BUY	$33.68 - $44.74 $6.4 Million - $8.51 Million	190,121 Added 71.62%	455,564 $17.8 Million
Q2 2024 Aug 14, 2024	SELL	$23.57 - $34.85 $6.46 Million - $9.56 Million	-274,223 Reduced 50.81%	265,443 $9.08 Million
Q1 2024 May 15, 2024	BUY	$24.92 - $30.02 $7.86 Million - $9.47 Million	315,290 Added 140.52%	539,666 $13.6 Million
Q4 2023 Feb 14, 2024	BUY	$27.14 - $34.93 $6.09 Million - $7.84 Million	224,376 New	224,376 $6.62 Million
Q1 2023 May 15, 2023	BUY	$19.19 - $24.1 $294,815 - $370,248	15,363 New	15,363 $369,000
Q2 2022 Aug 15, 2022	SELL	$18.42 - $27.5 $425,778 - $635,662	-23,115 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$15.5 - $23.93 $383,563 - $592,171	-24,746 Reduced 51.7%	23,115 $509,000
Q4 2021 Feb 14, 2022	SELL	$13.05 - $19.35 $1.11 Million - $1.64 Million	-84,725 Reduced 63.9%	47,861 $763,000
Q3 2021 Nov 15, 2021	BUY	$13.95 - $20.18 $1.22 Million - $1.77 Million	87,615 Added 194.83%	132,586 $2.64 Million
Q2 2021 Aug 16, 2021	SELL	$15.84 - $20.6 $599,876 - $780,142	-37,871 Reduced 45.71%	44,971 $778,000
Q1 2021 May 17, 2021	SELL	$16.29 - $21.92 $3.16 Million - $4.25 Million	-194,033 Reduced 70.08%	82,842 $1.64 Million
Q4 2020 Feb 16, 2021	BUY	$15.75 - $25.45 $1.04 Million - $1.67 Million	65,796 Added 31.17%	276,875 $4.83 Million
Q3 2020 Nov 16, 2020	BUY	$18.4 - $26.59 $3.68 Million - $5.32 Million	200,241 Added 1847.58%	211,079 $4.07 Million
Q2 2020 Aug 14, 2020	SELL	$11.51 - $20.97 $972,123 - $1.77 Million	-84,459 Reduced 88.63%	10,838 $211,000
Q1 2020 May 14, 2020	BUY	$9.38 - $23.79 $684,983 - $1.74 Million	73,026 Added 327.9%	95,297 $1.33 Million
Q4 2019 Feb 14, 2020	SELL	$6.84 - $25.9 $705,566 - $2.67 Million	-103,153 Reduced 82.24%	22,271 $546,000
Q3 2019 Nov 14, 2019	BUY	$9.16 - $14.77 $1.15 Million - $1.85 Million	125,424 New	125,424 $1.26 Million

Others Institutions Holding MIRM

# of Institutions

229

Shares Held

56.1M

Call Options Held

25.3K

Put Options Held

98.9K

View Full List

About Mirum Pharmaceuticals, Inc.

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $2.38B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

More about MIRM

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account